Sagimet Biosciences Inc. SGMT
9.24
0.13
1.43%
as of 25 Sep
- Market cap
- $561.1M
- P/E
- 0.0×
Follow SGMT
| Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | — | — |
P/S ratio |
— | — | — | — | 0.00 | — | — |
P/FCF ratio |
— | — | — | — | 0.00 | — | — |
P/Operating CF |
— | — | — | — | (7.87) | — | — |
P/B ratio |
— | — | — | — | 0.61 | — | — |
Price to Tangible BV |
— | — | — | — | 0.61 | — | — |
EV/Sales |
— | — | — | — | 0.00 | — | — |
EV/EBITDA |
— | — | — | — | 1.27 | — | — |
EV/Operating CF |
— | — | — | — | 1.64 | — | — |
EV/FCF |
— | — | — | — | 1.64 | — | — |
Quick Ratio |
4.92 | 35.97 | 23.25 | 6.13 | 16.78 | 33.96 | 22.18 |
Current Ratio |
5.21 | 35.99 | 23.46 | 6.21 | 17.09 | 34.30 | 22.82 |
Net Debt/EBITDA |
0.70 | 6.07 | 2.39 | 1.03 | 3.08 | 2.72 | 1.98 |
Debt/Assets |
3.06% | 0.30% | 0.59% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.04 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
Operating CF/Net income |
0.74 | 0.92 | 0.89 | 0.80 | 0.85 | 0.93 | 0.89 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 8.71% | 16.62% | 17.67% | 58.14% | (36.92%) | (38.20%) | |
| 0.00% | (28.38%) | (38.19%) | (66.26%) | (42.97%) | (35.46%) | (36.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (747.17%) | 0.00% |
Return on Tangible Assets |
(157.46%) | (16.96%) | (44.33%) | (110.85%) | (30.64%) | (30.72%) | (45.86%) |
Average Days of Receivables |
— | — | — | — | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 988.85% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 648.15% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 249.50% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | 1.63 | — | — |
Graham Number |
— | — | — | — | 0.00 | — | — |
Earnings Yield |
— | — | — | — | (50.00%) | — | — |
Free Cash Flow Yield |
— | — | — | — | (42.63%) | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.00 | 0.00 |
Operating CF per Share |
(0.49) | (0.49) | (1.02) | (132.67) | (2.27) | (1.35) | (1.41) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.49) | (0.49) | (1.02) | (132.67) | (2.27) | (1.35) | (1.41) |
Cash per Share |
0.48 | 3.21 | 2.65 | 175.22 | 9.07 | 4.82 | 3.50 |
Shareholders Equity per Share |
0.41 | 3.13 | 2.64 | (1,012.73) | 8.71 | 4.97 | 3.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.41 | 3.13 | 2.64 | (1,012.73) | 8.71 | 4.97 | 3.44 |
Free Cash Flow |
(10.55) | (10.42) | (21.71) | (24.49) | (23.77) | (42.43) | (45.65) |
Working Capital |
8.74 | 66.83 | 54.80 | 27.51 | 90.99 | 148.32 | 111.30 |
Net Current Asset Value |
8.52 | 66.75 | 54.57 | (187.19) | 90.99 | 148.32 | 111.30 |
EV/EBIT |
— | — | — | — | 1.27 | — | — |
Capex to Sales |
— | — | — | — | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | (1,393.80%) | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | — | 0.00 | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.28 | 0.64 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(55.98%) | (7.81%) | (19.44%) | 15.84% | (12.78%) | (13.82%) | (20.33%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Payables |
— | — | — | — | 0.66 | 0.81 | 1.37 |
Average Assets |
— | 40.06 | 64.00 | 46.03 | 64.88 | 128.49 | 138.37 |
Average Common Equity |
— | (130.61) | (147.08) | (172.60) | (47.94) | 123.44 | 133.59 |
Columns are period end dates